CCM
TELA icon

CAAS Capital Management’s TELA Bio TELA Stock Holding History

CAAS Capital Management’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,263
Closed -$154K – 1392
2020
Q4 		$154K Sell
10,263
-15,468
-60% -$251K ﹤0.01% 777
2020
Q3 		$426K Sell
25,731
-49,269
-66% -$692K 0.01% 400
2020
Q2 		$972K Buy
+75,000
New +$985K 0.03% 272

Other funds holding TELA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

CAAS Capital Management's TELA Position: Q1 2021 in Review

CAAS Capital Management sold out of TELA Bio (TELA) in Q1 2021, closing a stake of 10,263 shares — an estimated $154K sold.

CAAS Capital Management first reported a position in TELA in Q2 2020 and held it in 3 quarters. The position peaked at $972K in Q2 2020. 47 funds tracked by Wall St. Rank hold TELA as of Q1 2021.

  • CAAS Capital Management reported no remaining TELA Bio position as of Q1 2021 after selling out during the quarter.
  • CAAS Capital Management sold 10,263 TELA Bio shares in Q1 2021, an estimated $154K.
  • CAAS Capital Management first reported a position in TELA Bio in Q2 2020 and held it in 3 quarters.
  • CAAS Capital Management's TELA Bio position peaked at $972K in Q2 2020.
  • 47 funds tracked by Wall St. Rank held TELA Bio as of Q1 2021.

Based on CAAS Capital Management's 13F filing for Q1 2021, filed 17 May 2021.